Recommended Reading

Obalon Therapeutics has executed a consulting agreement with Blue Ox Healthcare Partners, a private equity firm focused on commercial-ready companies bringing technology enabled innovation to healthcare, especially those involved in precision health, healthcare delivery and affo

Researchers from Michigan Medicine team has providing new insights into why patients with severe hyperglycaemia may trigger worse outcomes in people infected with COVID-19.